Conclusion and Results
One month after completing radiotherapy, the patient had a CT
re-examination on July 3, 2023, which showed a significant reduction in
the lung cancer lesion (see Figure 3,a2, b2,c2,d2) compared to before
the radiotherapy (see Figure 3,a1, b1,c1,d1). No significant
abnormalities were found in liver and kidney functions or blood
analysis. Through the bronchoalveolar lavage fluid test combined with
non-tuberculosis mycobacteria detection, the DNA of non-tuberculosis
mycobacteria was found to be positive, but no tuberculosis mycobacteria
were detected. Based on the consultation instructions from the
tuberculosis department’s doctor, the patient’s anti-tuberculosis
treatment was effective.
After two cycles, a therapeutic evaluation was conducted, revealing a
slight reduction in the lung cancer lesion(see Figures 3 ,a3,b3,c3,d3)
compared to before the chemotherapy(see Figure 3,a2, b2,c2,d2).
On December 16th, 2023, The patient completed anti-tuberculosis
treatment. The treatment for pulmonary tuberculosis was effective, and
no significant abnormalities were found in liver and kidney functions or
blood analysis.
On December 26th, 2023, The patients was reexamined for the first time
after all treatments finished. CT showed that the lung lesions were
significantly smaller than before treatment (Fig 4 A,B), and the DNA of
non-tuberculosis mycobacteria and tuberculosis mycobacteria weren’t
detected.
In short, after treatments, the patient’s tumor was obviously reduced
and stabilized, tuberculosis was cured. Both anti-tuberculosis treatment
and Anti-tumor treatment is effective.